Stroke Prevention With Abciximab in Carotid Endarterectomy

Trial Profile

Stroke Prevention With Abciximab in Carotid Endarterectomy

Withdrawn prior to enrolment
Phase of Trial: Phase I/II

Latest Information Update: 23 Dec 2015

At a glance

  • Drugs Abciximab (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Dec 2015 Status changed from discontinued to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
    • 27 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top